375 related articles for article (PubMed ID: 25171721)
1. Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors.
Lam SK; Sayama C; Harris DA; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2014 Nov; 14(5):476-85. PubMed ID: 25171721
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
[TBL] [Abstract][Full Text] [Related]
4. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
[TBL] [Abstract][Full Text] [Related]
5. Patient-, procedure-, and hospital-related risk factors of allogeneic and autologous blood transfusion in pediatric spinal fusion surgery in the United States.
Lam SK; Pan IW; Harris DA; Sayama CM; Luerssen TG; Jea A
Spine (Phila Pa 1976); 2015 Apr; 40(8):560-9. PubMed ID: 25646747
[TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: Off-label rhBMP-2 use in pediatric spine deformity surgery.
Kiely PD; Cunningham ME
J Neurosurg Pediatr; 2015 May; 15(5):545-6. PubMed ID: 25723726
[No Abstract] [Full Text] [Related]
7. Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery: an analysis of 4817 patients.
Jain A; Kebaish KM; Sponseller PD
J Bone Joint Surg Am; 2013 Jul; 95(14):1265-70. PubMed ID: 23864174
[TBL] [Abstract][Full Text] [Related]
8. Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.
Rumalla K; Yarbrough CK; Pugely AJ; Koester L; Dorward IG
J Neurosurg Spine; 2016 Oct; 25(4):500-508. PubMed ID: 27203810
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature.
Rocque BG; Kelly MP; Miller JH; Li Y; Anderson PA
J Neurosurg Pediatr; 2014 Dec; 14(6):635-43. PubMed ID: 25303159
[TBL] [Abstract][Full Text] [Related]
11. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
[TBL] [Abstract][Full Text] [Related]
12. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
13. A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2).
Wetzell B; McLean JB; Dorsch K; Moore MA
J Orthop Surg Res; 2021 Nov; 16(1):680. PubMed ID: 34794470
[TBL] [Abstract][Full Text] [Related]
14. Noninstrumented Lumbar Fusion with Bone Morphogenetic Proteins for Spinal Stenosis with Spondylolisthesis in the Elderly.
Bindal S; Bindal SK; Bindal M; Bindal AK
World Neurosurg; 2019 Jun; 126():e1427-e1435. PubMed ID: 30904805
[TBL] [Abstract][Full Text] [Related]
15. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
17. The feasibility and safety of using sublaminar polyester bands in hybrid spinal constructs in children and transitional adults for neuromuscular scoliosis.
Desai SK; Sayama C; Vener D; Brayton A; Briceño V; Luerssen TG; Jea A
J Neurosurg Pediatr; 2015 Mar; 15(3):328-37. PubMed ID: 25555118
[TBL] [Abstract][Full Text] [Related]
18. Usage of recombinant human bone morphogenetic protein in cervical spine procedures: analysis of the MarketScan longitudinal database.
Cole T; Veeravagu A; Jiang B; Ratliff JK
J Bone Joint Surg Am; 2014 Sep; 96(17):1409-16. PubMed ID: 25187578
[TBL] [Abstract][Full Text] [Related]
19. Complications in Adult Patients with Down Syndrome Undergoing Cervical Spine Surgery Using Current Instrumentation Techniques and rhBMP-2: A Long-Term Follow-Up.
Siemionow K; Hansdorfer M; Janusz P; Mardjetko S
J Neurol Surg A Cent Eur Neurosurg; 2017 Mar; 78(2):113-123. PubMed ID: 27448197
[No Abstract] [Full Text] [Related]
20. Insights into complication rates, reoperation rates, and healthcare utilization associated with use of recombinant human bone morphogenetic protein-2 in patients with spine infections.
Sharma M; Dietz N; Alhourani A; Ugiliweneza B; Wang D; Drazin D; Boakye M
Neurosurg Focus; 2019 Jan; 46(1):E8. PubMed ID: 30611165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
